May 2, 2025
Joe Raedle/Getty Images

Will the FDA approve the first new drug to help people quit smoking in 20 years?

Firm working on first new stop smoking drug in nearly 20 years will seek FDA approval in June for cytisinicline, promises fewer side effects than Chantix.

By Sarah Todd


STAT+ | Collins and fellow GOP senators speak out in opposition to Trump’s cuts to biomedical research

Trump's canceled NIH grants and HHS layoffs threaten U.S. biomedical leadership, Collins says, as she calls for funding to be restored.

By John Wilkerson


STAT+ | Despite Kennedy’s stated support, funding for Women’s Health Initiative remains in limbo

Funding for a landmark health study, the Women's Health Initiative, was set to end then reportedly saved, but researchers still await confirmation.

By Elizabeth Cooney



Hoover Tower on the Stanford University campus.
Justin Sullivan/Getty Images

STAT+ | At Stanford conference, typically guarded biotech leaders share their concerns about Trump policies

At Stanford conference, biotech leaders say Trump policies are disrupting science and FDA staffing, putting U.S. biomedical ecosystem at risk

By Jonathan Wosen


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.